Buscar
Mostrando ítems 1-10 de 344
Colloidal carriers for ophthalmic drug delivery
(Bentham Science Publ Ltd, 2005-05-01)
To achieve effective drug concentration at the intended site for a sufficient period of time is a requisite desired for many drug formulations. For drugs intended to ocular delivery, its poor bioavailability is due to ...
Colloidal carriers for ophthalmic drug delivery
(Bentham Science Publ Ltd, 2005-05-01)
To achieve effective drug concentration at the intended site for a sufficient period of time is a requisite desired for many drug formulations. For drugs intended to ocular delivery, its poor bioavailability is due to ...
Estudos sobre liberação controlada e vetorização de drogas através de lipossomas
(2005-06-01)
The text highlights the state of research related with the application of liposomes in the control of drug delivery and drug target to infectious diseases. Liposomes have several pharmaceutical applications and this ...
Estudos sobre liberação controlada e vetorização de drogas através de lipossomas
(2005-06-01)
The text highlights the state of research related with the application of liposomes in the control of drug delivery and drug target to infectious diseases. Liposomes have several pharmaceutical applications and this ...
Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery
(2006-07-17)
The use of the nasal route for drug delivery has attracted much interest in recent years in the pharmaceutical field. Local and principally systemic drug delivery can be achieved by this route of administration. But the ...
Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery
(2006-07-17)
The use of the nasal route for drug delivery has attracted much interest in recent years in the pharmaceutical field. Local and principally systemic drug delivery can be achieved by this route of administration. But the ...
Colloidal carriers for ophthalmic drug delivery
(Bentham Science Publ Ltd, 2014)
Improvement of antischistosomal activity of praziquantel by incorporation into phosphatidylcholine-containing liposomes
(Elsevier B.V., 2005-05-13)
Praziquantel (PZQ) is effective against all known species of Schistosomes that infect humans. The failure of mass treatment of schistosomiasis has been attributed to the fact that therapy is not sufficiently long-lasting. ...